Open AccessExperience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Author(s) -
Ingmar Königsrainer,
Derek Zieker,
Jörg Glatzle,
Olivia Lauk,
Julia Anna Klimek,
Stephan Symons,
Björn L.D.M. Brücher,
Stefan Beckert,
Alfred Königsrainer
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i17.2061
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , conventional pci , perioperative , surgery , contraindication , cytoreductive surgery , multimodal therapy , body mass index , cancer , myocardial infarction , ovarian cancer , alternative medicine , pathology
To investigate perioperative patient morbidity/mortality and outcome after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).